Effectiveness and safety of azithromycin 1.5% eye drops for mass treatment of active trachoma in a highly endemic district in Cameroon

BMJ Open Ophthalmology
Assumpta Lucienne Françoise BellaDidier Renault

Abstract

To evaluate the effectiveness and safety of azithromycin 1.5% eye drops under field conditions to reduce active trachoma in a highly endemic district in Cameroon. This is a follow-up of an initial report published in 2010. Three annual campaigns were performed in 2008, 2009 and 2010 to treat the population (~1 20 000 individuals) of the Kolofata Health District with topical azithromycin 1.5% (one drop in each eye, morning and evening for three consecutive days). The effectiveness of this intervention against active trachoma was assessed in children aged 1-9 years in cross-sectional studies prior to each mass treatment using a systematic sampling procedure (in 2008, 2009 and 2010) and then 1 year (2011) and 3 years (2013) after the last intervention among the villages with previously high active trachoma prevalence or never tested. The prevalence of trachomatous inflammation-follicular (TF) dropped from 24.0% (95% CI 20.7 to 27.5) before treatment to 2.8% (95% CI 2.2 to 3.7) 1 year after completion of the 3 year campaign. Trachomatous inflammation-intense was present in only 4 (0.2%) children 1 year after the third round of treatment. Three years after the last campaign, the surveillance survey among the most prevalent villages ...Continue Reading

References

Jul 27, 2001·Ophthalmic Epidemiology·S K WestM C Lynch
Jun 28, 2005·Transactions of the Royal Society of Tropical Medicine and Hygiene·Nicola DesmondDavid C W Mabey
Jun 10, 2008·Lancet·Heathcote R WrightHugh R Taylor
Apr 9, 2010·Tropical Medicine & International Health : TM & IH·Victor H HuDavid C W Mabey
Dec 3, 2010·PLoS Neglected Tropical Diseases·Abdou AmzaLucienne Bella-Assumpta
Mar 24, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeremy D KeenanThomas M Lietman
May 30, 2013·PLoS Neglected Tropical Diseases·Blaise Noa NoatinaAssumpta Lucienne Françoise Bella
Sep 7, 2013·PLoS Neglected Tropical Diseases·Sheila K WestThomas C Quinn
Feb 15, 2014·The British Journal of Ophthalmology·Dominique Bremond-GignacUNKNOWN AZI Study Group
May 9, 2014·Tropical Medicine and Health·Pablo Goldschmidt, Ellen Einterz
Jul 22, 2014·Lancet·Hugh R TaylorHeathcote Wright
Mar 24, 2015·PLoS Neglected Tropical Diseases·Violeta JimenezDanny Haddad
Oct 17, 2017·The Lancet Global Health·Seth R FlaxmanUNKNOWN Vision Loss Expert Group of the Global Burden of Disease Study
Jun 4, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas M LietmanTravis C Porco
Oct 8, 2018·The Lancet Infectious Diseases·Kieran S O'BrienCatherine E Oldenburg
Jan 31, 2019·Expert Review of Anti-infective Therapy·Meraf A Wolle, Sheila K West
Sep 25, 2019·The American Journal of Tropical Medicine and Hygiene·Aisha E P StewartScott D Nash

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

EPIINFO

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.